1. PURPOSE OF THIS PAGE
Why These References Are Listed
MedLlama provides AI-assisted medical and clinical information. Because artificial intelligence can generate incomplete, outdated, or incorrect content, clinically important information should be independently checked against authoritative medical references. This page identifies reputable scientific, clinical, regulatory, and evidence-based resources that healthcare professionals, students, trainees, researchers, and other qualified users may consult when verifying information.
Important Clarification
This page is not a claim that every MedLlama answer is directly retrieved from, quoted from, or individually checked against every organization or publication listed below. Unless a specific MedLlama response explicitly identifies a source, users should not assume that the response was generated from a particular guideline, publication, database, or organization.
Independent Verification
The most appropriate source depends on the question being reviewed. Drug information should generally be checked against current approved labeling and trusted pharmacology resources; clinical recommendations against current professional guidelines; scientific claims against peer-reviewed literature; and imaging, pathology, laboratory, or specialty-specific questions against the appropriate professional standard and specialist literature.
2. EVIDENCE HIERARCHY & SOURCE QUALITY
Evidence Is Not Equal
Medical information can come from many types of sources, including randomized controlled trials, systematic reviews, meta-analyses, observational studies, consensus statements, clinical practice guidelines, regulatory documents, case reports, textbooks, educational websites, and expert opinion. These sources differ substantially in reliability, relevance, and applicability to an individual clinical question.
Prefer Current Authoritative Sources
For clinically important decisions, preference should generally be given to current authoritative guidelines, official regulatory labeling, high-quality systematic reviews, well-designed peer-reviewed studies, and specialty-specific professional recommendations. Older publications may remain scientifically important but can be superseded by newer evidence, revised guidelines, updated drug labeling, or new safety information.
Patient and Context Differences
Even high-quality evidence may not apply equally to every patient. Age, sex, pregnancy, comorbidities, organ function, medications, genetics, disease severity, local resistance patterns, healthcare setting, and other clinical factors may change how evidence should be interpreted.
3. WORLD HEALTH ORGANIZATION (WHO)
WHO Guidelines
The World Health Organization publishes evidence-based global recommendations concerning clinical care, public health, infectious disease, noncommunicable disease, screening, prevention, treatment, health systems, and other health topics
Official resource
https://www.who.int/publications/who-guidelines
How WHO Guidelines Are Developed
WHO states that its guidelines are developed through a transparent, evidence-based process and are subject to quality assurance through its guideline-development framework. WHO recommendations may be particularly useful for global health, public-health policy, infectious disease, vaccination, prevention, and international clinical guidance.
Use With Local Guidance
WHO recommendations may need to be interpreted together with national, regional, specialty-specific, or institution-specific guidance because standards of care, medicine availability, epidemiology, and legal requirements can differ between jurisdictions.
4. PUBMED & NATIONAL LIBRARY OF MEDICINE
PubMed
PubMed is a biomedical literature search resource maintained by the U.S. National Library of Medicine. It provides access to citations and abstracts from biomedical and life-sciences literature and is an important starting point for identifying original research, reviews, clinical studies, and medical publications
Official resource
https://pubmed.ncbi.nlm.nih.gov
How to Use PubMed Responsibly
Finding a paper in PubMed does not automatically establish that the paper provides high-quality evidence. Users should consider study design, sample size, population, methods, conflicts of interest, statistical quality, peer-review status, date of publication, replication, and consistency with the broader evidence base.
5. COCHRANE EVIDENCE
Systematic Reviews
Cochrane produces systematic reviews and evidence summaries intended to support informed healthcare decision-making. Cochrane reviews can be useful when evaluating the totality of evidence concerning interventions, benefits, harms, diagnostic strategies, and other healthcare questions
Official resource
https://www.cochrane.org/evidence
Interpretation
A systematic review is only as strong as the available evidence and its methodology. Conclusions can change when new trials are published, when evidence quality is low, or when a review is updated.
6. NICE GUIDELINES
National Institute for Health and Care Excellence
NICE develops evidence-based guidance and recommendations used widely in the United Kingdom and internationally. NICE resources cover clinical care, medicines, diagnostics, public health, health technologies, and other areas of healthcare
Official resource
https://www.nice.org.uk/guidance
Jurisdictional Context
NICE recommendations are developed within a UK healthcare and regulatory context. They can be valuable scientific references internationally, but users should verify whether local guidelines, medicine approvals, reimbursement rules, or standards of care differ in their own jurisdiction.
7. U.S. CENTERS FOR DISEASE CONTROL AND PREVENTION (CDC)
Clinical and Public Health Guidance
The U.S. Centers for Disease Control and Prevention publishes clinical and public-health information concerning infectious diseases, vaccination, antimicrobial issues, travel health, epidemiology, prevention, and other health topics
Official resource
https://www.cdc.gov
Current Guidance Matters
CDC recommendations can change in response to new evidence, outbreaks, surveillance information, emerging pathogens, resistance patterns, and updated public-health policy. For time-sensitive infectious-disease questions, users should verify that they are consulting the current version of the relevant CDC guidance.
8. U.S. PREVENTIVE SERVICES TASK FORCE (USPSTF)
Preventive Recommendations
The U.S. Preventive Services Task Force publishes evidence-based recommendations concerning preventive services such as screening, counseling, and preventive interventions
Official resource
https://www.uspreventiveservicestaskforce.org
Population-Specific Recommendations
USPSTF recommendations are commonly defined for particular ages, risk groups, or clinical populations. Users should review the exact recommendation population and grade rather than applying a recommendation outside its intended context.
9. FDA MEDICINE & SAFETY INFORMATION
U.S. Food and Drug Administration
The U.S. Food and Drug Administration provides official regulatory information about medicines, biologics, medical devices, safety communications, recalls, labeling, and other regulated health products
Official resource
https://www.fda.gov
Current Product Labeling
For medication-specific questions, current approved labeling and official safety communications should be consulted when clinically relevant. Drug labeling can change because of new indications, contraindications, boxed warnings, dosage information, safety signals, interactions, or post-market findings.
10. DAILYMED
Official Drug Labeling Repository
DailyMed is maintained by the U.S. National Library of Medicine and provides current labeling submitted to the U.S. Food and Drug Administration by manufacturers. It includes labeling for prescription and nonprescription medicines and can be used to verify indications, dosage and administration, contraindications, warnings, adverse reactions, interactions, and other official product information
Official resource
https://dailymed.nlm.nih.gov
Labeling Is Product-Specific
Medication names may exist in different formulations, strengths, routes, manufacturers, or jurisdictions. Users should verify that they are reviewing the correct product and formulation rather than relying only on a generic medicine name.
11. EUROPEAN MEDICINES AGENCY (EMA)
European Medicine Information
The European Medicines Agency publishes regulatory and scientific information for medicines evaluated at the European Union level. EMA medicine pages may include the Summary of Product Characteristics, package leaflet, scientific assessment information, safety updates, and regulatory status
Official resource
https://www.ema.europa.eu
Product Information
EMA product information is an important reference for European medicine use, but national authorization pathways and country-specific requirements may also apply.
12. AMERICAN COLLEGE OF RADIOLOGY (ACR)
ACR Appropriateness Criteria
The American College of Radiology publishes evidence-based Appropriateness Criteria to support healthcare professionals in selecting appropriate imaging and image-guided procedures for defined clinical scenarios
Official resource
https://www.acr.org/clinical-resources/clinical-tools-and-reference/appropriateness-criteria
Imaging Context
ACR resources can help determine when specific imaging methods may be appropriate, but they do not replace formal interpretation of an individual patient's imaging examination by a qualified radiologist or other appropriately trained specialist.
13. RADIOLOGYINFO.ORG
ACR and RSNA Educational Resource
RadiologyInfo.org is produced by radiology organizations including the American College of Radiology and Radiological Society of North America. It contains professionally reviewed information about X-ray, CT, MRI, ultrasound, nuclear medicine, interventional radiology, radiation therapy, safety, and preparation for imaging examinations
Official resource
https://www.radiologyinfo.org
Educational Role
RadiologyInfo.org is useful for understanding imaging procedures and general imaging information. It should not be treated as an individual patient's radiology report or specialist interpretation.
14. EUROPEAN SOCIETY OF CARDIOLOGY (ESC)
Cardiovascular Guidelines
The European Society of Cardiology publishes clinical practice guidelines covering cardiovascular diagnosis, prevention, risk assessment, heart failure, arrhythmias, coronary disease, valvular disease, hypertension-related cardiovascular care, and other cardiology topics
Official resource
https://www.escardio.org/Guidelines/Clinical-Practice-Guidelines
Clinical Application
ESC guidelines provide evidence-based frameworks for clinical decision-making. Individual recommendations should be interpreted according to the patient's clinical context and the version of the guideline currently in force.
15. AMERICAN HEART ASSOCIATION & ACC
Cardiovascular Guidance
The American Heart Association and American College of Cardiology publish scientific statements, clinical practice guidelines, resuscitation guidance, and cardiovascular recommendations
Official resources
https://www.heart.org
Official resources 2
https://www.acc.org/guidelines
Verify the Latest Version
Cardiovascular guidelines are periodically revised as evidence changes. Users should confirm the publication year, update status, and whether a guideline has been superseded.
16. AMERICAN DIABETES ASSOCIATION (ADA)
Standards of Care in Diabetes
The American Diabetes Association publishes the Standards of Care in Diabetes, which contain current clinical practice recommendations for diabetes care and are updated regularly
Official resource
https://professional.diabetes.org/standards-of-care
Scope
The Standards address areas including diagnosis, glycemic management, cardiovascular risk, kidney disease, eye disease, neuropathy, pregnancy, pediatric care, older adults, inpatient care, and other aspects of diabetes management.
17. SPECIALTY SOCIETY GUIDELINES
Use the Appropriate Specialty Source
For specialty-specific questions, users should consult current guidelines from the relevant recognized professional body. Examples may include cardiology, radiology, neurology, dermatology, infectious disease, oncology, endocrinology, nephrology, gastroenterology, psychiatry, obstetrics and gynecology, pediatrics, emergency medicine, surgery, pathology, and clinical pharmacology organizations.
Not Every Society Recommendation Is Universal
Professional organizations may issue different recommendations based on evidence interpretation, healthcare-system context, available treatments, or local practice standards. When recommendations conflict, users should review the methodology, date, evidence quality, jurisdiction, and patient context rather than assuming that one recommendation universally overrides another.
18. GOOGLE MEDGEMMA SCIENTIFIC FOUNDATION
MedGemma
MedLlama may use MedGemma-family models as part of its AI pipeline. Google describes MedGemma as a family of medical AI models trained for medical text and image comprehension and intended to support development of downstream healthcare applications
Official model documentation
https://developers.google.com/health-ai-developer-foundations/medgemma/model-card
Model Limitations Matter
Google's MedGemma documentation states that MedGemma is a foundation model requiring appropriate validation and adaptation for specific downstream uses. The model documentation also emphasizes that generated outputs require independent verification and clinical correlation. A model's benchmark performance does not establish that every individual output is clinically correct.
Model Versions May Change
MedLlama may change or combine AI models over time. The presence of MedGemma in the MedLlama AI pipeline does not mean that every answer is produced exclusively by one MedGemma version.
19. FDA CLINICAL DECISION SUPPORT GUIDANCE
Clinical Decision Support Software
The U.S. Food and Drug Administration publishes guidance explaining its approach to certain Clinical Decision Support software functions
Official resource
https://www.fda.gov/regulatory-information/search-fda-guidance-documents/clinical-decision-support-software
Medical Image Analysis
FDA guidance distinguishes certain decision-support functions from software that acquires, processes, or analyzes medical images or signals. Regulatory classification depends on the actual software function, intended use, claims, and applicable law. A scientific-reference page does not determine the regulatory status of MedLlama or any specific MedLlama feature.
20. HOW TO VERIFY A MEDLLAMA RESPONSE
Step 1 — Identify the Claim
Determine exactly what the AI is claiming. Separate factual statements, interpretations, possible diagnoses, medication information, guideline recommendations, risk statements, and suggested next steps.
Step 2 — Identify the Best Source Type
Use the source most appropriate to the claim. For example: • drug labeling → FDA, DailyMed, EMA or relevant national authority; • guideline recommendation → current professional guideline; • scientific evidence → PubMed, systematic reviews and original literature; • imaging appropriateness → ACR or relevant radiology guideline; • specialty treatment question → current specialty-society guideline.
Step 3 — Check Date and Version
Confirm that the reference is current and has not been replaced, withdrawn, superseded, or materially updated.
Step 4 — Confirm Patient Applicability
Check whether the evidence applies to the patient's age, sex, pregnancy status, disease severity, comorbidities, medications, organ function, and clinical setting.
Step 5 — Resolve Conflicts
If MedLlama conflicts with an authoritative source, official report, current guideline, or professional clinical judgment, do not treat the AI output as controlling. Resolve the discrepancy using appropriate professional review and additional evidence.
21. REFERENCES DISPLAYED BY AI
AI-Generated Citations
AI systems can generate references that look plausible but are incorrect, incomplete, outdated, or nonexistent. A citation produced in an AI response should be verified by opening the original source and confirming that it exists and actually supports the claim.
Do Not Rely on Citation Appearance
A journal title, DOI, author name, guideline name, URL, or professional organization mentioned by AI does not by itself prove that the reference is authentic or that it supports the generated statement.
22. IMPORTANT LIMITATION
Scientific References Do Not Replace Clinical Judgment
Scientific literature and guidelines inform clinical decision-making but do not remove the need for professional judgment. Clinical recommendations must be interpreted in the context of the individual patient, available data, examination findings, local standards, and applicable law.
Read With MedLlama Safety Documents
This Scientific References page should be read together with MedLlama's Medical Disclaimer and Limitation of Liability, Terms of Service, and Privacy Policy.